Skinvive by Juvéderm Targets Neck Lines in New FDA Filing
If approved, Skinvive by Juvéderm will be the first hyaluronic acid injectable treatment option aiming to reduce neck lines.
If approved, Skinvive by Juvéderm will be the first hyaluronic acid injectable treatment option aiming to reduce neck lines.
Guidepoint Qsight’s Erik Haines breaks down the drivers behind 2024’s $17.5 billion in non-surgical aesthetic spending and what it signals for the future of the industry.
Plastic surgeon Paul S. Kim, MD, discusses his role in the Renewing Lives campaign and how minimally invasive skin-tightening treatments like Renuvion are helping patients address post-weight loss skin laxity.
A new report examines the key drivers, growth opportunities, and challenges shaping the hyaluronic acid dermal fillers market.
The October 2024 mission brought pediatric hand surgery to two Ukrainian hospitals and included training for local surgeons—all amid ongoing war conditions.